The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
about
What We Have Learned about Autism Spectrum Disorder from Valproic AcidUp-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acidInterferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylationRegulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancerAcetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylationHistone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I studyAntineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.Novel interaction between Apc5p and Rsp5p in an intracellular signaling pathway in Saccharomyces cerevisiaeDietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cellsE2s: structurally economical and functionally repleteHistone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signalingTargeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in miceHistone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionValproic acid causes proteasomal degradation of DICER and influences miRNA expressionHistone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injuryRegulation of mammalian epithelial differentiation and intestine development by class I histone deacetylasesThe ubiquitin ligase Rnf6 regulates local LIM kinase 1 levels in axonal growth cones.Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain developmentTranslational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cellsHighly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotencyHistone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsyPhase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomographyPlant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradationDifferential methylation is associated with non-syndromic cleft lip and palate and contributes to penetrance effectsEffect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells.Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo.Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior.Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function.Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression.A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.Functional activity of RLIM/Rnf12 is regulated by phosphorylation-dependent nucleocytoplasmic shuttlingEffects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell lineHistone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts
P2860
Q21284783-25EE9B62-093E-4369-AF3C-5A53C6DFD12CQ24288944-0B285471-632F-4057-885C-153C16132E8BQ24563471-6DA63BA7-71A5-43EF-B6DA-EA49BDC640C3Q24646768-A3602F63-026E-416A-A1C2-AFBB043D385DQ24797546-22323833-1435-448B-B01A-27B6DDA6B5DDQ24810933-6361409F-713E-4F15-B4B9-2597B2C28A7FQ25255934-5AD6E5B1-057D-4594-989A-6F5ADE72354EQ27853165-2AD74C79-132E-4714-9944-9DAEDA9C3211Q27931731-26AFF8C1-12A1-4666-A79E-3BDA7011C5C8Q28257534-51EF9F42-ACB6-4E4E-BAE8-D62586363C3AQ28301074-A0793C9A-499A-4282-A211-D9D7ACB306E2Q28473090-4A526944-2FA4-4A96-AA3C-A7B6AE745B78Q28487437-9FDE5AEB-3C5E-4164-B514-07E2CD696F52Q28505369-58743393-61CD-439F-992F-4430CCE4F09FQ28537678-A3EDE2DC-B6AA-45AB-8BC6-B07ECE56D983Q28569252-BCAA03C0-7F67-44ED-AE86-EB4FA429E972Q28585055-FAADE382-B50D-43CB-BDC3-1B00FC1C27E5Q28588990-FA7D8D8B-7804-4EF8-BA33-9A8547FB6531Q28594873-EFE7E6D9-15F1-4990-9B5D-656624B4731CQ28771393-DB359EE1-3CE2-437D-AACA-A03B834AA6C3Q29616797-C3E5B33E-C07E-4E05-BFCC-9FCA7040BE49Q30570559-A49CDEAE-FF26-492E-B527-B3F02E887024Q31139176-7657EC56-B98E-44E5-811E-327383427A51Q33388447-4EC0FC4B-EEFA-49E2-A1DB-9CC35DD88536Q33597363-2FCB4A16-5F0B-4E10-BEBC-037611364D07Q33604116-CD3BF33F-15B5-4841-9E0D-35764B7A98EEQ33606387-BE193D8A-88AE-4C1F-8812-B79655F5DB7CQ33695448-A8E14151-132D-47B5-97A2-A35A3A076B3DQ33732655-38757BDA-93ED-4F17-9555-1DBFBA617FEDQ33755618-40A154BA-35CF-46F6-A264-FCC1D65B4160Q33794860-13E6BF81-F7AA-4D33-B951-A5BECFEB9267Q33842416-01BD6636-9478-4A13-85DC-8227317BF3EFQ33900608-F52FE40C-52FA-4AF9-88C8-8AAE4CEE18F3Q33923651-6441D240-D7EF-4FAA-A024-E215B92D286EQ33956241-E047A9B9-009E-4776-B3C6-26C3827BC9E0Q34097985-A0ADE037-87F1-4E0A-8571-9C164337F4AFQ34142430-09C1C2B7-5A87-47CF-A05D-D52714F41A94Q34361027-2D29D1C5-0774-499A-A1E7-B284CBC01404Q34366588-34AD01BB-DFE9-4C67-9179-F54E4B72C0CAQ34371044-8C228367-0153-4671-B0D6-727119196D92
P2860
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@ast
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@en
type
label
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@ast
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@en
prefLabel
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@ast
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@en
P2093
P2860
P356
P1433
P1476
The histone deacetylase inhibi ...... oteasomal degradation of HDAC2
@en
P2093
Bernd Groner
Boris Brill
Heather P Ostendorff
Ingolf Bach
Jens Tiefenbach
Martin Göttlicher
Marvin A Peters
Thorsten Heinzel
P2860
P304
P356
10.1093/EMBOJ/CDG315
P407
P577
2003-07-01T00:00:00Z